Microsoft Takes A Nuanced Approach to AI Healthcare

Artificial intelligence has become an invaluable tool in neuroscience due to its ability to vastly improve our understanding of the human brain, and therefore make us better equipped to diagnose and treat neurological disorders. Emerging…

RetinAI, Novartis, and Sankara remain vulnerable to competitors

AI has become the state-of-the-art method for vision tasks such as image classification and deep learning algorithms have been used successfully in ophthalmology to detect diseases such as diabetic retinopathy, age-related macular…

There’s A Patent Gap In AI Dermatology And Google May Be In Trouble

In May 2021, Google announced an artificial intelligence dermatology tool designed to help users understand issues with their skin, hair, and nails from the comfort of their own homes. The tool requires a user to take a picture of their…

AI is the Future for Surgery. Stryker Knows It.

It has been five years since Wright and Tornier merged and adopted the Wright Medical Group name. Stryker then acquired Wright Medical Group in 2020. The acquisition is an IP boon to Stryker, as Wright Medical had 16 patent assets publish…

Is T-Mobile Developing a Wearable?

Have you ever looked at your phone and immediately felt your stress and blood pressure increase due to a phone call? What if you had a wearable device that is able to correlate your stress with a phone call and screen the call for…

Closedloop.Ai Has Stiff Competitors, No Patents. Cue Ominous Shark Soundtrack.

It is important to protect your inventions but apparently AI biotech software companies such as  Closedloop.AI and others don’t see it that way. This may be the result of disarray caused by Alice in 2014 or the constant change in guidance…

Why Patent Assets Helped Secure $80 Million for Tesseract Health

Patent assets provide competitive advantage for a company, even when it is not the first entrant to a market. Retinal imaging and artificial intelligence is not a new concept (See (1) RetinAi,  (2) Diagnos, (3) PixelPlex, and (4) DeepMind…

Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees

Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest for promotion, it might have exaggerated a bit.  In early April 2021, Cala Health had 2 patent…

Capital One is Investing in AI Biotech? What’s in their wallet?

In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they belong? While 2 assets in 18 months may not seem substantial on the surface, the AI Biotech field is…

Google AI Reinvents Speech Recognition. Who will follow?

There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in many areas - except perhaps one. For example, of the big 5, only Google has patent data in the…

Sony is Exploring the AI/Biotech Diagnostics Sector. Ask us how we know.

When people think of Sony products, they usually think of audio, visual, and storage devices. That is because a majority of Sony's products fall into one of these categories. However, Sony's recent patent activity suggests that it may be…

Bose Boasts Biotech that Sets It Apart

Bose Corporation has been a well-known leader in the audio industry for quite a while. However, in the past few years, we have seen the rise of other audio leaders competitors such as Apple and Samsung. While Bose has continued to develop…

Apex Neuro Inventions May Be Poised to Impact the Neuromodulation Field

Investment in patents always leads market activity.  So Apex Neuro's investments in key research and development implicate its positioning for market launch in the coming years. So far, Patent Forecast shows 5 patent assets from Apex Neuro…

Neurology Companies Take Note: A New Data Management Player has Entered the Field

On February 25th, a new competitor joined the increasingly crowded space in the Neurology Sector. Rune Labs, a San Francisco-based biotech startup had 4 applications published. Each of these documents teach a system or method related to…

The First Company to use Genomic Data for Fitness Recommendations. Should other Companies Take Note?

There is no doubt that improved technologies have greatly reduced the amount of time necessary to sequence human genomes. In the past, it would take weeks or even months to sequence a single person's genome. Modern technology has greatly…

Are Insurance Companies the Next Entrants to the Neurology Sector?

The neurology sector has traditionally been led by large tech-focused companies such as IBM, Boston Scientific, and Phillips Inc. That being said, occasionally we also see companies not traditionally considered “tech” companies receive…

Should Google or Amazon be Eyeing Frontive? Should You be Eyeing Frontive?

When it comes to in-home voice assistants, there are two clear leaders: Amazon and Google. Both of these Big Five technology companies offer a variety of options from either the Google Home or Amazon Echo  product lines. Now that both…

You’ll get a kick out of this

Sufferers of Restless Leg Syndrome (RLS) will tell you that there is nothing worse than trying to fall asleep with restless legs. The disorder, which affects nearly 3 million people annually in the US, is characterized by a nearly…

Patent data fills in the cracks where Google data lacks

This past week, Neurostim OAB Inc. had two more patent applications published in the AI Biotech/Diagnostic sector.  This brings their total document count to 10 applications, all of which were published after April 2020. While simply…

Movano holds the missing key for‚”Apple?‚”Samsung?

This past week, Movano Inc. had its 3rd patent issued. The patent, U.S. Pat. No. 10,888,242, teaches a method and system of monitoring various health parameters from a small sensor embedded into a smartphone case. Notably, the sensor…

Patent Data as an Early Warning of New Competitors

Well-organized patent data can really make a difference for your company. One of the most powerful benefits of patent data is that it allows you to better understand your competitor landscape. Most established companies know who the big…

When Sectors Collide: Cannabis meets AI Biotech/Diagnostics

There is no doubt that our interest in cannabis has grown in recent years. Every week we see new patent data in our Cannabis Patent Forecast®  that indicates that many companies are developing awesome new technologies associated with…

Using Patent Data to Make Sense of Seemingly Questionable Business Deals

Although there are numerous benefits to monitoring patent data, one of the most important involves staying up to date with what your competitors are doing. The right data can be especially useful to help understand why a competitor makes a…

Honda joins Toyota, GM and Affectiva in the race to build mood-sensing vehicles

This past week, Japanese car maker Honda Motor Co., Ltd. became the most recent vehicle manufacturer to gain IP in the Neurology Sector. However, while fresh IP is usually a good sign for a company, one might question whether investing in…

Cranial Prosthesis with Ultrasound Compatibility

Ultrasound is often a preferred imaging method due to its low cost, and lack of dangerous radiation, but it is unable to penetrate bone, and therefore cannot be used to monitor the brain. Gliaview's newest invention looks to address this…

Patent Forecast® gives you AI-driven, interactive data that identifies key innovators and first movers.

Includes interactive Patent Radian, real-time USPTO updates, and market insights.

TRY IT FREE FOR 7 DAYS